Effect of inhibition of extracellular signal‐regulated kinase on relaxations to β‐adrenoceptor agonists in porcine isolated blood vessels
暂无分享,去创建一个
[1] J A Peters,et al. Guide to Receptors and Channels (GRAC), 3rd edition , 2008, British journal of pharmacology.
[2] J. Lüdemann,et al. Impaired coronary function in Wistar Ottawa Karlsburg W rats—a new model of the metabolic syndrome , 2007, Pflügers Archiv - European Journal of Physiology.
[3] G. Giebisch,et al. Inhibition of MAPK stimulates the Ca2+-dependent big-conductance K channels in cortical collecting duct , 2006, Proceedings of the National Academy of Sciences.
[4] K. Kamata,et al. Mechanisms underlying lysophosphatidylcholine‐induced potentiation of vascular contractions in the Otsuka Long‐Evans Tokushima Fatty (OLETF) rat aorta , 2006, British journal of pharmacology.
[5] H. Meurs,et al. Protein kinase C potentiates homologous desensitization of the β2-adrenoceptor in bovine tracheal smooth muscle , 2006 .
[6] Chang-Kwon Lee,et al. Mitogen-activated protein kinase contributes to elevated basal tone in aortic smooth muscle from hypertensive rats. , 2005, European journal of pharmacology.
[7] I. Hall,et al. Agonist and Inverse Agonist Actions of β-Blockers at the Human β2-Adrenoceptor Provide Evidence for Agonist-Directed Signaling , 2003 .
[8] R. Clark,et al. β2-Adrenergic Receptor Lacking the Cyclic AMP-Dependent Protein Kinase Consensus Sites Fully Activates Extracellular Signal-Regulated Kinase 1/2 in Human Embryonic Kidney 293 Cells: Lack of Evidence for Gs/Gi Switching. , 2002 .
[9] E. Schiffrin,et al. Inhibition of mitogen-activated protein/extracellular signal-regulated kinase improves endothelial function and attenuates Ang II-induced contractility of mesenteric resistance arteries from spontaneously hypertensive rats , 2002, Journal of hypertension.
[10] Ying-Yu Chen,et al. Responsiveness, affinity constants and β‐adrenoceptor reserves for isoprenaline on aortae from normo‐, pre‐and hypertensive rats , 2002, The Journal of pharmacy and pharmacology.
[11] C. Hiley,et al. Protein kinase A-dependent and -independent effects of isoproterenol in rat isolated mesenteric artery: interactions with levcromakalim. , 2001, The Journal of pharmacology and experimental therapeutics.
[12] R. Roberts. Role of the extracellular signal‐regulated kinase (Erk) signal transduction cascade in α2 adrenoceptor‐mediated vasoconstriction in porcine palmar lateral vein , 2001, British journal of pharmacology.
[13] A. Fujimura,et al. Impaired β-adrenoceptor mediated venodilation in patients with diabetes mellitus. , 1999, British Journal of Clinical Pharmacology.
[14] F. Hobbs,et al. Identification of a Novel Inhibitor of Mitogen-activated Protein Kinase Kinase* , 1998, The Journal of Biological Chemistry.
[15] A. Quyyumi,et al. Decreased vasodilator response to isoproterenol during nitric oxide inhibition in humans. , 1997, Hypertension.
[16] Philip R. Cohen,et al. PD 098059 Is a Specific Inhibitor of the Activation of Mitogen-activated Protein Kinase Kinase in Vitro and in Vivo(*) , 1995, The Journal of Biological Chemistry.
[17] M. Randall,et al. The involvement of ATP‐sensitive potassium channels in β‐adrenoceptor‐mediated vasorelaxation in the rat isolated mesenteric arterial bed , 1995, British journal of pharmacology.
[18] L. Poston,et al. β‐Adrenoceptor agonist mediated relaxation of rat isolated resistance arteries: a role for the endothelium and nitric oxide , 1993 .
[19] C. Stevens,et al. Aquaporin 4 and glymphatic flow have central roles in brain fluid homeostasis , 2021, Nature Reviews Neuroscience.
[20] W. J. Merrell,et al. Low sodium intake corrects abnormality in β‐receptor–mediated arterial vasodilation in patients with hypertension: Correlation with β‐receptor function in vitro , 1990 .
[21] J A Peters,et al. Guide to Receptors and Channels (GRAC), 2nd edition (2007 Revision). , 2007, British journal of pharmacology.
[22] Malcolm W Johnson. Molecular mechanisms of β2-adrenergic receptor function, response, and regulation , 2006 .
[23] P. Cohen,et al. Specificity and mechanism of action of some commonly used protein kinase inhibitors. , 2000, The Biochemical journal.
[24] A. Fujimura,et al. Impaired beta-adrenoceptor mediated venodilation in patients with diabetes mellitus. , 1999, British Journal of Clinical Pharmacology.
[25] S. Watts,et al. Integration of mitogen-activated protein kinase kinase activation in vascular 5-hydroxytryptamine2A receptor signal transduction. , 1998, The Journal of pharmacology and experimental therapeutics.
[26] K. Murray,et al. Cyclic AMP and mechanisms of vasolidation , 1990 .
[27] K. Murray,et al. Cyclic AMP and mechanisms of vasodilation. , 1990, Pharmacology & therapeutics.